Racial Disparities in Colon Cancer Survival
Jeffrey H. Silber(American Society of Clinical Oncology), Bruce J. Giantonio(Massachusetts General Hospital), Paul R. Rosenbaum(Children's Hospital of Philadelphia), Justin Ludwig(Children's Hospital of Philadelphia), Bijan A. Niknam(Children's Hospital of Philadelphia), Kevin R. Fox(Hospital of the University of Pennsylvania), Min Wang(Lanzhou University), Wei Wang(Air Force Medical University), Orit Even‐Shoshan(Children's Hospital of Philadelphia), Richard N. Ross(Children's Hospital of Philadelphia), Amy S. Clark(Abramson Center for Jewish Life)
Cited by 92
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
|Nature Medicine|2019|521
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
|Clinical Cancer Research|2021|358